Hari Kumar Email and Phone Number
Hari Kumar work email
- Valid
- Valid
- Valid
- Valid
Hari Kumar personal email
Hari Kumar is a Member of the External Board at UCL Global Business School for Health. He possess expertise in pharmaceutical industry, management, leadership, drug discovery, biotechnology and 15 more skills.
Ucl Global Business School For Health
View- Website:
- ucl.ac.uk/archaeology-south-east
- Employees:
- 73
-
Member Of The External BoardUcl Global Business School For HealthBasel, Bs, Ch -
Member Of The External BoardUcl Global Business School For Health Sep 2021 - PresentLondon, England, United Kingdom -
Chairman Of The BoardKinarus Therapeutics Ag Jun 2022 - PresentBasel, SwitzerlandKinarus AG is a Swiss biotechnology company that has a phase 2 clinical stage asset (KIN001) being developed in the treatment of Covid19. KIN001 is unique in that it is not only anti-viral, but also has direct anti-inflammatory and anti-fibrotic properties. This potentially makes it a First-in-Class oral treatment for Covid19.
-
Member Of Board Of DirectorsPanmira Pharmaceuticals Llc Jun 2013 - PresentGreater San Diego Area
-
Chief Executive OfficerPanmira Pharmaceuticals Llc Oct 2011 - Jun 2013San Diego
-
Chief Business OfficerPanmira Pharmaceuticals Llc Sep 2011 - Oct 2011Greater San Diego AreaPanmira Pharmaceuticals is a spinout from Amira Pharmaceuticals which was acquired by Bristol Myers-Squibb Inc. Panmira will focus on managing the assets that were spun out of Amira.
-
Board MemberTrio - Translational Research In Oncology Feb 2020 - Feb 2022Edmonton, Alberta, Canada -
Member Board Of DirectorsBiovie Inc. ; Bullet Biotechnology, Inc. May 2017 - Mar 2021
-
ConsultantRoche Oct 2015 - Apr 2017San Francisco Bay AreaTransitioning Adheron to Roche and helping the asset, SDP 051 move along the development path. -
Member Of Board Of DirectorsCymabay Therapeutics Jun 2012 - Jun 2016Hayward, Ca
-
Ceo And Board MemberAdheron Therapeutics Inc Jul 2013 - Oct 2015San Francisco Bay AreaAdheron Therapeutics (formerly known as Synovex Corporation) is a biotechnology company that is focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases. Roche acquires Adheron for $580M in October 2015 -
Chief Business OfficerAmira Pharmaceuticals Oct 2007 - Sep 2011 -
Global Business Development DirectorHoffmann-La Roche Jul 2003 - Dec 2006Basel Area, Switzerland -
Global Lifecycle Leader, TransplantationRoche Nov 1999 - Jul 2003Basel Area, Switzerland -
European Marketing DirectorEisai Ltd 1996 - 1999
-
Business Unit ManagerRoche Products Ltd. 1988 - 1996
Hari Kumar Skills
Hari Kumar Education Details
-
Immunology -
Unversity Of MalayaBiochemistry
Frequently Asked Questions about Hari Kumar
What company does Hari Kumar work for?
Hari Kumar works for Ucl Global Business School For Health
What is Hari Kumar's role at the current company?
Hari Kumar's current role is Member of the External Board.
What is Hari Kumar's email address?
Hari Kumar's email address is ha****@****ira.com
What schools did Hari Kumar attend?
Hari Kumar attended University Of London, Unversity Of Malaya.
What skills is Hari Kumar known for?
Hari Kumar has skills like Pharmaceutical Industry, Management, Leadership, Drug Discovery, Biotechnology, Clinical Development, Lifesciences, Drug Development, Oncology, Technology Transfer, Biopharmaceuticals, Commercialization.
Not the Hari Kumar you were looking for?
-
Hari Kumar
Ceo At Arya Vaidyasala Kottakkal | Driving Transformation And Change Across Multiple SectorsKottakkal1hotmail.com -
-
-
Hari Kumar
Chennai
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial